ES2167682T3 - Derivados del acido neuraminico, su preparacion y su uso medico. - Google Patents
Derivados del acido neuraminico, su preparacion y su uso medico.Info
- Publication number
- ES2167682T3 ES2167682T3 ES97305159T ES97305159T ES2167682T3 ES 2167682 T3 ES2167682 T3 ES 2167682T3 ES 97305159 T ES97305159 T ES 97305159T ES 97305159 T ES97305159 T ES 97305159T ES 2167682 T3 ES2167682 T3 ES 2167682T3
- Authority
- ES
- Spain
- Prior art keywords
- sup
- derivatives
- preparation
- medical use
- neuraminic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- CERZMXAJYMMUDR-QBTAGHCHSA-N 5-amino-3,5-dideoxy-D-glycero-D-galacto-non-2-ulopyranosonic acid Chemical class N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO CERZMXAJYMMUDR-QBTAGHCHSA-N 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
COMPUESTOS DE FORMULA (I): [EN LOS QUE R SUP,1} ES UN ALQUILO O HALOALQUILO; R SUP,2} Y R SUP,3} CADA UNO REPRESENTAN HIDROGENO O ACILO ALIFATICO; X ES HIDROXI, HALOGENO, ALCOXI, O UN GRUPO DE FORMULA R SUP,A}O-, DONDE R SUP,A} ES UN ACILO ALIFATICO; Y ES UN GRUPO DE FORMULA R SUP,B}R SUP,C}N R SUP,C}N-O-, DONDE R SUP,B} Y R SUP,C} SON CADA UNO HIDROGENO O ALQUILO; Y Z ES OXIGENO O AZUFRE] POSEEN UNA EXCELENTE ACTIVIDAD INHIBIDORA DE SIALIDASA, Y SON POR CONSIGUIENTE UTILES PARA EL TRATAMIENTO Y PREVENCION DE LA GRIPE Y OTRAS ENFERMEDADES VIRALES, EN LAS QUE LA REPLICACION DEL VIRUS ES SUSCEPTIBLE A INHIBIDORES DE LA SIALIDASA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP19186296 | 1996-07-22 | ||
| JP8688897 | 1997-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2167682T3 true ES2167682T3 (es) | 2002-05-16 |
Family
ID=26427962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97305159T Expired - Lifetime ES2167682T3 (es) | 1996-07-22 | 1997-07-11 | Derivados del acido neuraminico, su preparacion y su uso medico. |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0823428B1 (es) |
| KR (1) | KR100506578B1 (es) |
| CN (1) | CN1127494C (es) |
| AT (1) | ATE211468T1 (es) |
| AU (1) | AU700926B2 (es) |
| CA (1) | CA2210492C (es) |
| CZ (1) | CZ291960B6 (es) |
| DE (1) | DE69709795T2 (es) |
| DK (1) | DK0823428T3 (es) |
| ES (1) | ES2167682T3 (es) |
| HK (1) | HK1007879A1 (es) |
| HU (1) | HU223494B1 (es) |
| ID (1) | ID17474A (es) |
| IL (1) | IL121305A (es) |
| MX (1) | MX9705559A (es) |
| NO (1) | NO317704B1 (es) |
| NZ (1) | NZ328353A (es) |
| PT (1) | PT823428E (es) |
| RU (1) | RU2124509C1 (es) |
| TW (1) | TW418200B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451766B1 (en) | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6340702B1 (en) | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6455571B1 (en) | 1998-04-23 | 2002-09-24 | Abbott Laboratories | Inhibitors of neuraminidases |
| US6518305B1 (en) | 1998-04-23 | 2003-02-11 | Abbott Laboratories | Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| US6593314B1 (en) | 1999-10-19 | 2003-07-15 | Abbott Laboratories | Neuraminidase inhibitors |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| FR2809104B1 (fr) * | 2000-05-19 | 2002-08-02 | Univ Paris Curie | Procede de traitement de matiere vegetale, compositions comportant des derives du type n-acylglucosamine, utilisation de ces composes en tant qu'agents bio- protecteurs, et matiere vegetale traitee. |
| WO2001087876A1 (fr) * | 2000-05-19 | 2001-11-22 | Sankyo Company, Limited | Derives d'acide sialique |
| AUPR001000A0 (en) | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| WO2002076980A1 (fr) * | 2001-03-27 | 2002-10-03 | Sankyo Company, Limited | Derives d'acide sialique |
| WO2002092555A1 (fr) * | 2001-05-11 | 2002-11-21 | Sankyo Company, Limited | Derives d'acides sialiques |
| PL2123271T3 (pl) * | 2007-03-07 | 2012-03-30 | Daiichi Sankyo Co Ltd | Lek do leczenia grypy |
| TWI549956B (zh) * | 2007-04-11 | 2016-09-21 | 第一三共股份有限公司 | 神經胺酸衍生物及其製造方法 |
| KR100930963B1 (ko) * | 2008-02-26 | 2009-12-11 | 한국기계연구원 | 적층형 압전파이로트 밸브를 이용한 공조기용 팽창밸브 |
| JP2012510456A (ja) | 2008-11-28 | 2012-05-10 | シプラ・リミテッド | ザナミビルの製造方法及び該方法に使用するための中間体 |
| TWI491416B (zh) | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | 吸入用乾燥粉末醫藥組成物 |
| AU2010247141A1 (en) | 2009-05-15 | 2011-12-15 | Redx Pharma Plc | Redox drug derivatives |
| CN102532080A (zh) * | 2010-12-29 | 2012-07-04 | 中国科学院上海药物研究所 | 新型唾液酸衍生物及其制备方法,包含该衍生物的药物组合物,以及其用途 |
| CA2859296C (en) * | 2011-12-16 | 2016-10-11 | Daiichi Sankyo Company, Limited | Method for manufacturing neuraminic acid derivatives |
| WO2015032357A1 (zh) * | 2013-09-09 | 2015-03-12 | 中国科学院上海有机化学研究所 | 扎那米韦和拉那米韦的中间体及其合成方法 |
| CN114843564B (zh) * | 2022-03-28 | 2023-08-25 | 电子科技大学 | 一种阴阳离子共掺杂的固体氧化物电池氧电极材料及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK282950B6 (sk) * | 1990-04-24 | 2003-01-09 | Biota Scientific Management Pty Ltd | Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze |
| CA2081068C (en) * | 1991-10-23 | 2005-11-29 | Laurence Mark Von Itzstein | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| GB9400206D0 (en) * | 1994-01-07 | 1994-03-02 | Glaxo Group Ltd | Chemical compound |
| AUPM354694A0 (en) * | 1994-01-27 | 1994-02-17 | Biota Scientific Management Pty Ltd | Chemical compounds |
| GB9516276D0 (en) * | 1995-08-08 | 1995-10-11 | Biota Scient Management | Chemical compounds |
-
1997
- 1997-07-11 PT PT97305159T patent/PT823428E/pt unknown
- 1997-07-11 DE DE69709795T patent/DE69709795T2/de not_active Expired - Lifetime
- 1997-07-11 AT AT97305159T patent/ATE211468T1/de active
- 1997-07-11 ES ES97305159T patent/ES2167682T3/es not_active Expired - Lifetime
- 1997-07-11 DK DK97305159T patent/DK0823428T3/da active
- 1997-07-11 EP EP97305159A patent/EP0823428B1/en not_active Expired - Lifetime
- 1997-07-14 IL IL12130597A patent/IL121305A/xx not_active IP Right Cessation
- 1997-07-15 CA CA002210492A patent/CA2210492C/en not_active Expired - Lifetime
- 1997-07-16 AU AU28662/97A patent/AU700926B2/en not_active Expired
- 1997-07-16 NZ NZ328353A patent/NZ328353A/en not_active IP Right Cessation
- 1997-07-21 RU RU97113367A patent/RU2124509C1/ru active
- 1997-07-21 NO NO19973363A patent/NO317704B1/no not_active IP Right Cessation
- 1997-07-21 ID IDP972509A patent/ID17474A/id unknown
- 1997-07-21 CZ CZ19972316A patent/CZ291960B6/cs not_active IP Right Cessation
- 1997-07-21 TW TW086110312A patent/TW418200B/zh not_active IP Right Cessation
- 1997-07-22 KR KR1019970034213A patent/KR100506578B1/ko not_active IP Right Cessation
- 1997-07-22 HU HU9701270A patent/HU223494B1/hu active IP Right Grant
- 1997-07-22 CN CN97117883A patent/CN1127494C/zh not_active Expired - Lifetime
- 1997-07-22 MX MX9705559A patent/MX9705559A/es unknown
-
1998
- 1998-06-25 HK HK98106680A patent/HK1007879A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT823428E (pt) | 2002-04-29 |
| HK1007879A1 (en) | 1999-04-30 |
| IL121305A0 (en) | 1998-01-04 |
| AU700926B2 (en) | 1999-01-14 |
| NO973363D0 (no) | 1997-07-21 |
| CZ231697A3 (cs) | 1998-02-18 |
| HUP9701270A2 (hu) | 1999-09-28 |
| DE69709795T2 (de) | 2002-09-26 |
| MX9705559A (es) | 1998-05-31 |
| DE69709795D1 (de) | 2002-02-28 |
| EP0823428A3 (en) | 1998-02-25 |
| KR980009253A (ko) | 1998-04-30 |
| DK0823428T3 (da) | 2002-02-18 |
| NO317704B1 (no) | 2004-12-06 |
| HUP9701270A3 (en) | 2002-08-28 |
| EP0823428B1 (en) | 2002-01-02 |
| CZ291960B6 (cs) | 2003-06-18 |
| HU9701270D0 (en) | 1997-09-29 |
| CA2210492A1 (en) | 1998-01-22 |
| EP0823428A2 (en) | 1998-02-11 |
| KR100506578B1 (ko) | 2005-12-26 |
| ATE211468T1 (de) | 2002-01-15 |
| NO973363L (no) | 1998-01-23 |
| AU2866297A (en) | 1998-07-02 |
| CN1127494C (zh) | 2003-11-12 |
| NZ328353A (en) | 1998-03-25 |
| ID17474A (id) | 1998-01-08 |
| HU223494B1 (hu) | 2004-08-30 |
| TW418200B (en) | 2001-01-11 |
| RU2124509C1 (ru) | 1999-01-10 |
| IL121305A (en) | 2003-01-12 |
| CN1172807A (zh) | 1998-02-11 |
| CA2210492C (en) | 2002-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2167682T3 (es) | Derivados del acido neuraminico, su preparacion y su uso medico. | |
| PT933993E (pt) | Compostos de ciclopentano substituidos, uteis como inibidores de neuraminidase | |
| ES2181725T3 (es) | Inhibidores de hiv proteasa. | |
| ES2160648T3 (es) | Derivados de piridina. | |
| BR9813973A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo para o tratamento de um paciente sofrendo de uma condição. | |
| CY1115117T1 (el) | Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα | |
| HUP0002224A1 (hu) | Virusellenes hatású benzimidazol-származékok | |
| BR0209271A (pt) | Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto | |
| BRPI9917007B8 (pt) | azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso | |
| EA200200471A1 (ru) | Конденсированные нафтиридины в качестве ингибиторов обратной транскриптазы вич | |
| BR0316883A (pt) | Derivado de piridazin-3(2h)-ona, composto, processo para a preparação de um composto composição farmacêutica, uso do composto, método para o tratamento de um sujeito que está sofrendo de uma condição patológica ou doença susceptìvel de melhora por meio de inibição da fosfodiesterase 4 e produto de combinação | |
| BR0009200A (pt) | Compostos e composições para o tratamento dedoenças associada com disfunção imune | |
| BR9813651A (pt) | Compostos antipicornavirais e métodos para o seu uso e preparação | |
| AR002012A1 (es) | Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto. | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| BR0007589A (pt) | Inibidores da proliferação de células | |
| ES2151600T3 (es) | Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih. | |
| AR002260A1 (es) | Compuestos derivados de acido [4-(indazol-3-il)-piperidin-1-il]-acetico, procedimiento para su preparacion, composicion farmacuetica que los contienen,el uso de los mismos en la preparacion de un agente terapeutico, metodo de tratamiento y compuestos intermediarios. | |
| DE69232417T2 (de) | Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren | |
| PT880520E (pt) | Derivados da benzo¬c|quinolizina sua preparacao e uso como inibidores da 5-alfa-reductase | |
| DK1248768T3 (da) | Substituerede acylguanidiner, fremgangsmåde til deres fremstilling, deres anvendelse som medikamenter eller diagnostika samt medikamenter, der indeholder disse | |
| BR9608147A (pt) | Método para descontaminação microbiana de plaquetas sanguìneas. | |
| KR890005140A (ko) | 항비루스제 | |
| NO951608L (no) | Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon | |
| ES2063305T3 (es) | Derivados de bifenilo, procedimiento para la preparacion de los mismos e intermedios para los mismos. |